Expert Review of Molecular Diagnostics

Papers
(The H4-Index of Expert Review of Molecular Diagnostics is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Evaluating tumor cell- and T cell-derived extracellular vesicles as potential biomarkers of cancer and immune cell competence87
Cost analyses for malaria molecular diagnosis for research planners in India and beyond69
Mild behavioral impairment and neurodegeneration: time for a biomarker-based assessment65
Metabolic profile of the Warburg effect as a tool for molecular prognosis and diagnosis of cancer50
Recent updates in the development of molecular assays for the rapid identification and susceptibility testing of MRSA42
What makes a « good » companion diagnostic in thoracic oncology?35
Clinicopathological, etiological and molecular characteristics of intrahepatic cholangiocarcinoma subtypes classified by mucin production and immunohistochemical features33
Analytical validation of a novel multi-target blood-based test to detect hepatocellular carcinoma31
Molecular point-of-care testing in the community pharmacy setting: current status and future prospects31
Polygenic and Network-based studies in risk identification and demystification of cancer30
Cancer cell-derived extracellular vesicles activate hepatic stellate cells in colorectal cancer29
Retrospective analysis of the risk factors associated with failure in obtaining effective noninvasive prenatal test results and pregnancy outcomes: a case-control study29
Alzheimer’s disease: a scoping review of biomarker research and development for effective disease diagnosis27
Harnessing the potential of genomic characterization of mutational profiles to improve early diagnosis of lung cancer27
Nuclease activity: an exploitable biomarker in bacterial infections27
Molecular charcterization of lung adenocarcinoma combining whole exome sequencing, copy number analysis and gene expression profiling25
Evolution and future of cervical cancer screening: from cytology to primary HPV testing and the impact of vaccination25
Unlocking the power of biomarkers: transforming the diagnosis of acute respiratory distress syndrome24
Diagnostic approach to leptomeningeal involvement in diffuse large B-cell lymphoma23
A novel anoikis-related signature predicts prognosis risk and treatment responsiveness in diffuse large B-cell lymphoma22
RAD51 as a functional biomarker for homologous recombination deficiency in cancer: a promising addition to the HRD toolbox?22
The current and future applications of in situ hybridization technologies in anatomical pathology21
Genetic risk and gastric cancer: polygenic risk scores in population-based case-control study21
Functional proteomic analysis, a missing piece for understanding clonal evolution and cooperation in the tissue microecology21
The MALAT1-breast cancer interplay: insights and implications21
0.066852807998657